Skip to main content
. Author manuscript; available in PMC: 2019 Mar 4.
Published in final edited form as: Biomimetics (Basel). 2017 Oct 5;2(4):10.3390/biomimetics2040019. doi: 10.3390/biomimetics2040019

Figure 2.

Figure 2

Characterization of conjugated dopamine-modified hyaluronic acid: (A) Ultraviolet–visible (UV–vis) spectra of the control (HA) and the catechol-based conjugate (HA-DN). 1H-nuclear magnetic resonance (NMR) spectra of (B) HA; (C) DN and (D) the synthesized conjugate HA-DN, all with an expanded view. a.u.: Arbitrary units.